{"id":17779,"date":"2025-03-12T09:47:35","date_gmt":"2025-03-12T08:47:35","guid":{"rendered":"https:\/\/www.medipan.de\/?page_id=17779"},"modified":"2026-03-30T11:27:30","modified_gmt":"2026-03-30T10:27:30","slug":"newsletter","status":"publish","type":"page","link":"https:\/\/www.medipan.de\/de\/newsletter\/","title":{"rendered":"Newsletter"},"content":{"rendered":"\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-cover is-light has-parallax wp-elements-d80af36138bce2b64ae8c9316fa55d1c\" style=\"min-height:200px;aspect-ratio:unset;\"><div class=\"wp-block-cover__image-background wp-image-16279 has-parallax\" style=\"background-position:50% 50%;background-image:url(https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/01\/Frau-im-Labor_AdobeStock_157618786-scaled.jpeg)\"><\/div><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim\" style=\"background-color:#d5dfe7\"><\/span><div class=\"wp-block-cover__inner-container is-layout-constrained wp-block-cover-is-layout-constrained\">\n<p class=\"has-text-align-center has-large-font-size\"><\/p>\n<\/div><\/div>\n\n\n\n<div class=\"getresponse-inline-widget\">\n<getresponse-form form-id=\"6fa91c12-c6ed-4cf7-b342-4038dc4169e9\" e=\"0\"><\/getresponse-form>\n<\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" src=\"https:\/\/www.medipan.de\/wp-content\/uploads\/2024\/03\/AdobeStock_200277632-scaled-e1718186576393-1024x686.jpeg\" alt=\"Laboratory assistants in uniform and protective glasses working with test tubes in the medical laboratory\" class=\"wp-image-9897 size-full\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<h4 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">Pr\u00e4zision in der Diagnostik &#8211; weltweit<\/mark><\/h4>\n\n\n\n<p>Medipan &amp; GA Generic Assays entwickeln hochmoderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung bieten wir fortschrittliche IFA-, LINE- und Dot-Immunoblot-, RIA-, ELISA- sowie Lateral-Flow-Technologien an. Diese L\u00f6sungen unterst\u00fctzen Labore und Kliniken in mehr als 60 L\u00e4ndern und tragen zur Verbesserung der Diagnostik und Patientenversorgung bei.<\/p>\n<\/div><\/div>\n\n\n\n<p class=\"has-white-background-color has-background\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">Inhalte<\/mark><\/strong><br>Wir informieren Sie \u00fcber aktuelle Themen und Entwicklungen im Bereich der Diagnostik, mit besonderem Fokus auf die Autoimmundiagnostik, sowie \u00fcber exklusive Einblicke und die neuesten innovativen Diagnostika von Medipan &amp; GA Generic Assays.<\/p>\n\n\n\n<p class=\"has-white-background-color has-background\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">Doppeltes Opt-in und Opt-out<\/mark><br><\/strong>Sie erhalten eine Double-Opt-In-E-Mail, in der Sie aufgefordert werden, Ihre Anmeldung zu best\u00e4tigen. Sie k\u00f6nnen dem Erhalt des Newsletters jederzeit widersprechen (Opt-out). In jedem Newsletter oder in der Double-Opt-in-E-Mail finden Sie einen Link zum Abbestellen.<\/p>\n\n\n\n<p class=\"has-white-background-color has-background\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">H\u00e4ufigkeit des Newsletter-Versands<\/mark><br><\/strong>Der Newsletter wird ca. einmal im Monat verschickt. Die Frequenz ist abh\u00e4ngig von der aktuellen Marktsituation, der Relevanz der Themen und den Entwicklungen im Bereich der Diagnostik. Die Newsletter werden haupts\u00e4chlich auf Englisch verschickt. Wir stehen jedoch weiterhin zur Verf\u00fcgung, um Antworten und Materialien in deutscher Sprache bereitzustellen.<\/p>\n\n\n\n<p class=\"has-white-background-color has-background\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">Informationen zum Datenschutz<\/mark><br><\/strong>Ausf\u00fchrliche Informationen zum Versandverfahren und zu Statistiken sowie zu Ihren Opt-out-M\u00f6glichkeiten finden Sie in unserer <a href=\"https:\/\/www.medipan.de\/de\/medipan-gmbh\/#tab4\" target=\"_blank\" rel=\"noreferrer noopener\">Medipan Datenschutzerkl\u00e4rung<\/a> und in der <a href=\"https:\/\/www.medipan.de\/de\/ga-generic-assays-gmbh\/#tab4\" target=\"_blank\" rel=\"noreferrer noopener\">GA Generic Assay Datenschutzerkl\u00e4rung<\/a>.<\/p>\n\n\n\n<p class=\"has-white-background-color has-background\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-dark-color\">Verwendung von GetResponse<\/mark><br><\/strong>Der Versand des Newsletters erfolgt \u00fcber \u201eGetResponse\u201c, das auch die E-Mail-Adressen und andere Informationen f\u00fcr den Versand und die Analyse des Newsletters speichert.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pr\u00e4zision in der Diagnostik &#8211; weltweit Medipan &amp; GA Generic Assays entwickeln hochmoderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung bieten wir fortschrittliche IFA-, LINE- und Dot-Immunoblot-, RIA-, ELISA- sowie Lateral-Flow-Technologien an. Diese L\u00f6sungen unterst\u00fctzen Labore und Kliniken in mehr als 60 L\u00e4ndern und tragen zur Verbesserung der Diagnostik und Patientenversorgung bei. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":17993,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-17779","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Newsletter - Medipan &amp; GA Generic Assays<\/title>\n<meta name=\"description\" content=\"Medipan &amp; GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.medipan.de\/de\/newsletter\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newsletter - Medipan &amp; GA Generic Assays\" \/>\n<meta property=\"og:description\" content=\"Medipan &amp; GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.medipan.de\/de\/newsletter\/\" \/>\n<meta property=\"og:site_name\" content=\"Medipan &amp; GA Generic Assays\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/Medipan-GA-Generic-Assays\/pfbid02ULuoTqAH3VaVSiKK1yK6und3uDLDWT5sPtqVXyQHcW1QBfBX1ywC47X62DBGZgril\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T10:27:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/03\/linkedin-new.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1584\" \/>\n\t<meta property=\"og:image:height\" content=\"396\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/\",\"url\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/\",\"name\":\"Newsletter - Medipan &amp; GA Generic Assays\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.medipan.de\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/linkedin-new.png\",\"datePublished\":\"2025-03-12T08:47:35+00:00\",\"dateModified\":\"2026-03-30T10:27:30+00:00\",\"description\":\"Medipan & GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.medipan.de\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/linkedin-new.png\",\"contentUrl\":\"https:\\\/\\\/www.medipan.de\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/linkedin-new.png\",\"width\":1584,\"height\":396,\"caption\":\"Ein Bild, das als Hintergrundprofil f\u00fcr soziale Medien verwendet wird.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/newsletter\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsletter\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/\",\"name\":\"Medipan.de\",\"description\":\"Your reliable partner in autoimmune diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#organization\",\"name\":\"Medipan GmbH & GA Generic Assays GmbH\",\"url\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.medipan.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/logo_transparent.png\",\"contentUrl\":\"https:\\\/\\\/www.medipan.de\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/logo_transparent.png\",\"width\":108,\"height\":49,\"caption\":\"Medipan GmbH & GA Generic Assays GmbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medipan.de\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/people\\\/Medipan-GA-Generic-Assays\\\/pfbid02ULuoTqAH3VaVSiKK1yK6und3uDLDWT5sPtqVXyQHcW1QBfBX1ywC47X62DBGZgril\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medipan-generic-assays-gmbh\\\/?originalSubdomain=de\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCFTKVg_v7n57CG7i9rPv-NQ\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Newsletter - Medipan &amp; GA Generic Assays","description":"Medipan & GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.medipan.de\/de\/newsletter\/","og_locale":"de_DE","og_type":"article","og_title":"Newsletter - Medipan &amp; GA Generic Assays","og_description":"Medipan & GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.","og_url":"https:\/\/www.medipan.de\/de\/newsletter\/","og_site_name":"Medipan &amp; GA Generic Assays","article_publisher":"https:\/\/www.facebook.com\/people\/Medipan-GA-Generic-Assays\/pfbid02ULuoTqAH3VaVSiKK1yK6und3uDLDWT5sPtqVXyQHcW1QBfBX1ywC47X62DBGZgril\/","article_modified_time":"2026-03-30T10:27:30+00:00","og_image":[{"width":1584,"height":396,"url":"https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/03\/linkedin-new.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.medipan.de\/de\/newsletter\/","url":"https:\/\/www.medipan.de\/de\/newsletter\/","name":"Newsletter - Medipan &amp; GA Generic Assays","isPartOf":{"@id":"https:\/\/www.medipan.de\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.medipan.de\/de\/newsletter\/#primaryimage"},"image":{"@id":"https:\/\/www.medipan.de\/de\/newsletter\/#primaryimage"},"thumbnailUrl":"https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/03\/linkedin-new.png","datePublished":"2025-03-12T08:47:35+00:00","dateModified":"2026-03-30T10:27:30+00:00","description":"Medipan & GA Generic Assays entwickeln moderne In-vitro-Diagnostika f\u00fcr Autoimmun- und Infektionskrankheiten. Mit \u00fcber 30 Jahren Erfahrung liefern wir IFA-, LINE-, Dot-Immunoblot-, RIA-, ELISA- und Lateral-Flow-Technologien f\u00fcr Labore und Kliniken weltweit.","breadcrumb":{"@id":"https:\/\/www.medipan.de\/de\/newsletter\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.medipan.de\/de\/newsletter\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.medipan.de\/de\/newsletter\/#primaryimage","url":"https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/03\/linkedin-new.png","contentUrl":"https:\/\/www.medipan.de\/wp-content\/uploads\/2025\/03\/linkedin-new.png","width":1584,"height":396,"caption":"Ein Bild, das als Hintergrundprofil f\u00fcr soziale Medien verwendet wird."},{"@type":"BreadcrumbList","@id":"https:\/\/www.medipan.de\/de\/newsletter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.medipan.de\/de\/"},{"@type":"ListItem","position":2,"name":"Newsletter"}]},{"@type":"WebSite","@id":"https:\/\/www.medipan.de\/de\/#website","url":"https:\/\/www.medipan.de\/de\/","name":"Medipan.de","description":"Your reliable partner in autoimmune diagnostics","publisher":{"@id":"https:\/\/www.medipan.de\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.medipan.de\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.medipan.de\/de\/#organization","name":"Medipan GmbH & GA Generic Assays GmbH","url":"https:\/\/www.medipan.de\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.medipan.de\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.medipan.de\/wp-content\/uploads\/2021\/01\/logo_transparent.png","contentUrl":"https:\/\/www.medipan.de\/wp-content\/uploads\/2021\/01\/logo_transparent.png","width":108,"height":49,"caption":"Medipan GmbH & GA Generic Assays GmbH"},"image":{"@id":"https:\/\/www.medipan.de\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/Medipan-GA-Generic-Assays\/pfbid02ULuoTqAH3VaVSiKK1yK6und3uDLDWT5sPtqVXyQHcW1QBfBX1ywC47X62DBGZgril\/","https:\/\/www.linkedin.com\/company\/medipan-generic-assays-gmbh\/?originalSubdomain=de","https:\/\/www.youtube.com\/channel\/UCFTKVg_v7n57CG7i9rPv-NQ"]}]}},"_links":{"self":[{"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/pages\/17779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/comments?post=17779"}],"version-history":[{"count":23,"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/pages\/17779\/revisions"}],"predecessor-version":[{"id":107918,"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/pages\/17779\/revisions\/107918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/media\/17993"}],"wp:attachment":[{"href":"https:\/\/www.medipan.de\/de\/wp-json\/wp\/v2\/media?parent=17779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}